Viewing Study NCT03773367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-06-25 @ 1:46 AM
Study NCT ID: NCT03773367
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2018-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
Sponsor: Lund University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Gastric and Gastroesophageal Junction Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastric adenocarcinoma View
None Gastroesophageal junction adenocarcinoma View
None Chemotherapy View
None Fluorouracil View
None Oxaliplatin View
None Irinotecan View
None Preoperative chemotherapy View
None Postoperative chemotherapy View
None Histopathological response View
None Rate of R0-resection View